-
Vetter Earns Prestigious Honors Across All Core Categories in the 13th Annual CDMO Leadership Awards
Biotech Newswire
March 27, 2024
Vetter once again earned the 2024 CDMO Leadership Awards in all six core categories – quality, expertise, reliability, capabilities, compatibility and service for big pharma, small pharma and overall respondents.
-
How could AI change drug development by ChatGPT
PharmaSources
February 26, 2024
Artificial Intelligence (AI) has the potential to significantly impact and revolutionize the field of drug development in several ways.
-
Overview of New "Don't Eat Me" Target CD24 Research
Zhaoruijie/PharmaSources
July 03, 2023
Recently, Antengene Corporation announced that the Phase I clinical trial application (IND) of its global first anti-CD24 monoclonal antibody, ATG-031, had been approved by FDA.
-
Development of Anticancer Drugs for Ferroptosis: An Analysis of Representative Natural Products
PharmaSources/Yuntian
May 08, 2021
Over the past years, anticancer strategies based on ferroptosis have been well acknowledged, leading to a boom in the development of anticancer drugs at home and abroad.
-
Alternative Method to Accelerate Drug Development
Lin Zhang
January 21, 2021
Drug development is an essential process in the pharmaceutical industry, however, it is also time-consuming and costly which contains preclinical, clinical and after-market.
-
Pharma and Health from Ingredients to Pills: Artificial Intelligence (AI) and Drug Development
Lin Zhang
December 09, 2020
Artificial Intelligence (AI) is gaining traction across a variety of sectors. AI can be used for a variety of goals and is likely to become a staple in drug development, among other things.
-
Advantages to Using CROs
Lin Zhang
November 12, 2020
Today, contract research organizations (CROs) provide crucial services for almost any point along the drug pipeline.
-
Simplifying AI Data Analysis for Scientists – as REPROCELL, IBM and STFC Hartree Centre Successfully Launch Pharmacology-AI Platform
PharmaSources
June 05, 2023
On June 1,2023,REPROCELL announces the launch of a new commercial service, Pharmacology-AI.
-
ProBioGen Launches Their Lentivirus Packaging Cell Line Lenti.RiGHT - A Shortcut to Successful Lentivirus Manufacturing
PharmaSources
May 18, 2023
May 17, 2023,ProBioGen announced the launch of their lentivirus (LV) packaging cell line Lenti.RiGHT as a new platinum standard for LV production at this year's PEGS Boston 2023.
-
SeraNovo and AstraZeneca to Collaborate on Research Projects
PharmaSources
May 16, 2023
SeraNovo is pleased to announce the closing of a multi-compound deal with AstraZeneca.SeraNovo (Leiden, The Netherlands) is pleased to announce the closing of a multi-compound deal with AstraZeneca.